119 related articles for article (PubMed ID: 3902866)
1. Increased gastric inhibitory polypeptide is not reduced in patients with noninsulin-dependent diabetes mellitus treated with intense insulin therapy.
Lardinois CK; Mazzaferri EL; Starich GH; Hollenbeck CB; Reaven GM
J Clin Endocrinol Metab; 1985 Dec; 61(6):1089-92. PubMed ID: 3902866
[TBL] [Abstract][Full Text] [Related]
2. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
Gutniak M; Grill V; Efendić S
J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
[TBL] [Abstract][Full Text] [Related]
3. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
[TBL] [Abstract][Full Text] [Related]
4. Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus.
Mazzaferri EL; Starich GH; Lardinois CK; Bowen GD
J Clin Endocrinol Metab; 1985 Aug; 61(2):313-21. PubMed ID: 4008608
[TBL] [Abstract][Full Text] [Related]
5. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.
Osei K; Falko JM; O'Dorisio TM; Fields PG; Bossetti B
J Clin Endocrinol Metab; 1986 Feb; 62(2):325-30. PubMed ID: 3510224
[TBL] [Abstract][Full Text] [Related]
6. A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the beta cell response or glucose tolerance in type 2 diabetes mellitus.
Jones IR; Owens DR; Vora J; Luzio SD; Hayes TM
Diabetes Res Clin Pract; 1989 Nov; 7(4):263-9. PubMed ID: 2693029
[TBL] [Abstract][Full Text] [Related]
7. Effect of source of dietary fats on serum glucose, insulin, and gastric inhibitory polypeptide responses to mixed test meals in subjects with non-insulin dependent diabetes mellitus.
Lardinois CK; Starich GH; Mazzaferri EL; DeLett A
J Am Coll Nutr; 1988 Apr; 7(2):129-36. PubMed ID: 3283195
[TBL] [Abstract][Full Text] [Related]
8. Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes.
Christensen MB; Calanna S; Holst JJ; Vilsbøll T; Knop FK
J Clin Endocrinol Metab; 2014 Mar; 99(3):E418-26. PubMed ID: 24423311
[TBL] [Abstract][Full Text] [Related]
9. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Nauck MA; Heimesaat MM; Orskov C; Holst JJ; Ebert R; Creutzfeldt W
J Clin Invest; 1993 Jan; 91(1):301-7. PubMed ID: 8423228
[TBL] [Abstract][Full Text] [Related]
10. Glucose-dependent insulin-releasing peptide in noninsulin-dependent maturity-onset diabetes: effects of autonomic neuropathy.
Levitt NS; Vinik AI; Child PT
J Clin Endocrinol Metab; 1980 Aug; 51(2):254-8. PubMed ID: 6995476
[TBL] [Abstract][Full Text] [Related]
11. Augmented gastric inhibitory polypeptide and insulin responses to a meal after an increase in carbohydrate (sucrose) intake.
Mazzaferri EL; Starich GH; St Jeor ST
J Clin Endocrinol Metab; 1984 Apr; 58(4):640-5. PubMed ID: 6365944
[TBL] [Abstract][Full Text] [Related]
12. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
[TBL] [Abstract][Full Text] [Related]
13. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
[TBL] [Abstract][Full Text] [Related]
14. The effect of glyburide on beta-cell sensitivity to glucose-dependent insulinotropic polypeptide.
Meneilly GS; Bryer-Ash M; Elahi D
Diabetes Care; 1993 Jan; 16(1):110-4. PubMed ID: 8422763
[TBL] [Abstract][Full Text] [Related]
15. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
Crockett SE; Mazzaferri EL; Cataland S
Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
[TBL] [Abstract][Full Text] [Related]
16. Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects.
Meier JJ; Nauck MA; Siepmann N; Greulich M; Holst JJ; Deacon CF; Schmidt WE; Gallwitz B
Metabolism; 2003 Dec; 52(12):1579-85. PubMed ID: 14669159
[TBL] [Abstract][Full Text] [Related]
17. Third Exposure to a Reduced Carbohydrate Meal Lowers Evening Postprandial Insulin and GIP Responses and HOMA-IR Estimate of Insulin Resistance.
Lin PJ; Borer KT
PLoS One; 2016; 11(10):e0165378. PubMed ID: 27798656
[TBL] [Abstract][Full Text] [Related]
18. Effect of source of dietary carbohydrate on plasma glucose, insulin, and gastric inhibitory polypeptide responses to test meals in subjects with noninsulin-dependent diabetes mellitus.
Coulston AM; Hollenbeck CB; Liu GC; Williams RA; Starich GH; Mazzaferri EL; Reaven GM
Am J Clin Nutr; 1984 Nov; 40(5):965-70. PubMed ID: 6388305
[TBL] [Abstract][Full Text] [Related]
19. Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits.
Gjesing AP; Ekstrøm CT; Eiberg H; Urhammer SA; Holst JJ; Pedersen O; Hansen T
Diabetologia; 2012 May; 55(5):1338-45. PubMed ID: 22349073
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
Krarup T; Madsbad S; Moody AJ
J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
